Kindly MD and Antalpha Secure $250M Convertible Debt Facility

Kindly MD, a healthcare data company, has signed a $250 million convertible debt facility deal with Antalpha. The company focuses on holistic pain management and reducing the opioid epidemic through direct healthcare services, prescription medicine, and behavioral health services. Its specialty outpatient clinical services are offered on a fee-for-service basis, and it collects data to assist and treat individual patients.

Kindly MD, Inc., a healthcare data company specializing in holistic pain management and reducing the impact of the opioid epidemic, has announced a strategic partnership with Antalpha Platform Holding Co. The agreement includes the establishment of a $250 million convertible debt facility. This facility is expected to provide Kindly MD with the necessary funding to expand its services and enhance its data collection capabilities.

Kindly MD offers a range of outpatient clinical services, including chronic pain management, functional medicine, cognitive behavioral therapy, and addiction therapy. These services are provided on a fee-for-service basis, allowing the company to capture valuable data on patient behavior and treatment outcomes. The company's primary goal is to reduce opioid use among chronic pain patients by integrating prescription medicine and behavioral health services.

The convertible debt facility, which is part of the strategic partnership with Antalpha, will allow Kindly MD to secure additional funding without diluting its equity. This funding will be crucial for the company's growth and expansion plans. The facility is structured to convert into equity at a future date, providing Antalpha with a stake in Kindly MD's success.

Antalpha, known for its innovative financial technology solutions, has expressed confidence in Kindly MD's mission and potential. The partnership underscores the growing interest in healthcare technology and data-driven solutions to address complex health issues like the opioid epidemic.

This strategic partnership and the $250 million convertible debt facility are significant milestones for Kindly MD. The funding will enable the company to continue its work in reducing opioid dependency and improving patient outcomes. As the healthcare industry increasingly focuses on data-driven solutions, Kindly MD's approach and partnership with Antalpha position it as a leader in this emerging field.

Kindly MD Announces Strategic Partnership With Antalpha & Intent To Establish $250 Million Convertible Debt Facility^[1] https://www.tradingview.com/news/reuters.com,2025:newsml_FWN3VN2WQ:0-kindly-md-announces-strategic-partnership-with-antalpha-intent-to-establish-250-million-convertible-debt-facility/
Kindly MD announces strategic partnership with Antalpha & intent to establish $250 million convertible debt facility^[2] https://www.marketscreener.com/news/kindly-md-announces-strategic-partnership-with-antalpha-intent-to-establish-250-million-convertible-debt-facility